TG Therapeutics Inc
(NASDAQ:TGTX)
$13.22
-0.61[-4.41%]
At close: Feb 20
$13.22
0[0.00%]
After Hours: 7:35PM EDT
Open13.750Close13.230
Vol / Avg.3.879M / 5.092MMkt Cap2.002B
Day Range13.165 - 13.85552 Wk Range6.460 - 35.670

TG Therapeutics Stock (NASDAQ:TGTX), Quotes and News Summary

TG Therapeutics Stock (NASDAQ: TGTX) stock price, news, charts, stock research, profile.

Open13.750Close13.230
Vol / Avg.3.879M / 5.092MMkt Cap2.002B
Day Range13.165 - 13.85552 Wk Range6.460 - 35.670
TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum
Globe Newswire - 15 hours ago
Precision BioSciences Receives Initial $7.5 Million Cash Payment and Equity Investment from TG Therapeutics for Azel-Cel in Treatment of Autoimmune Diseases
Business Wire - Feb 12, 2024, 7:00AM
Thinking about trading options or stock in TG Therapeutics, Microsoft, Eli Lilly And Co, Chevron, or Alcon?
PRNewswire - Jan 10, 2024, 9:31AM
TG Therapeutics Provides Preliminary Fourth Quarter and Full Year 2023 Net Revenue and 2024 Anticipated Milestones
Globe Newswire - Jan 10, 2024, 7:00AM
Biotech Bid Up Before Opening Bell
Yolowire - Jan 9, 2024, 9:44AM
TG Therapeutics Announces Global License Agreement with Precision BioSciences for the Development and Commercialization of Precision's Allogeneic CD19 CAR T Cell Therapy Program for the Treatment of Autoimmune Diseases
Globe Newswire - Jan 9, 2024, 7:00AM
Precision BioSciences Completes License Deal with TG Therapeutics for Cell Therapy Azer-Cel in Treatment of Autoimmune Diseases
Business Wire - Jan 9, 2024, 7:00AM
TG Therapeutics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
Globe Newswire - Jan 5, 2024, 7:30AM
TG Therapeutics to Participate in the 6th Annual Evercore ISI HealthCONx Conference
Globe Newswire - Nov 27, 2023, 7:30AM
TG Therapeutics to Participate in the 5th Annual Guggenheim Inflammation, Neurology & Immunology (INI) Conference
Globe Newswire - Nov 3, 2023, 7:30AM
Full archive of press releases available on Benzinga Pro
Sector: Health Care.Industry: Biotechnology

Earnings

see more
Q1 2024Est.ActualSurprise
EPS
(EXPECTED)
REV
Q4 2023Est.ActualSurprise
EPS
(EXPECTED)
REV

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
2024-02-05B. Riley SecuritiesMayank MamtaniMaintainsBuyBuyRaises24.0029.00
2024-01-11HC Wainwright & Co.Edward WhiteMaintainsBuyBuyRaises41.0045.00
2023-11-01JefferiesMatthew AndrewsMaintainsBuyBuy-23.00-
2023-11-01JP MorganEric JosephMaintainsOverweightOverweightRaises22.0023.00

Related Companies

TickerCompanyChg %Mkt Cap
TGTXTG Therapeutics-4.41%2B
TWSTTwist Bioscience-4.62%2.3B
SNDXSyndax Pharmaceuticals1.78%1.9B
PTCTPTC Therapeutics0.27%2B
IRWDIronwood Pharmaceuticals1.71%2.3B
Q

How do I buy TG Therapeutics (TGTX) stock?

A

You can purchase shares of TG Therapeutics (NASDAQ: TGTX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are TG Therapeutics's (TGTX) competitors?

Q

What is the target price for TG Therapeutics (TGTX) stock?

A

The latest price target for TG Therapeutics (NASDAQ: TGTX) was reported by B. Riley Securities on Monday, February 5, 2024. The analyst firm set a price target for 29.00 expecting TGTX to rise to within 12 months (a possible 119.36% upside). 23 analyst firms have reported ratings in the last year.

Q

Current Stock Price for TG Therapeutics (TGTX)?

A

The stock price for TG Therapeutics (NASDAQ: TGTX) is $13.22 last updated Today at February 20, 2024 at 7:35 PM EST.

Q

Does TG Therapeutics (TGTX) pay a dividend?

A

There are no upcoming dividends for TG Therapeutics.

Q

When is TG Therapeutics (NASDAQ:TGTX) reporting earnings?

A

TG Therapeutics’s Q1 earnings are confirmed for Monday, April 29, 2024.

Q

Is TG Therapeutics (TGTX) going to split?

A

There is no upcoming split for TG Therapeutics.

Q

What sector and industry does TG Therapeutics (TGTX) operate in?

A

TG Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.